BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23782082)

  • 1. Restoring hemostasis: fibrinogen concentrate versus cryoprecipitate.
    Elliott BM; Aledort LM
    Expert Rev Hematol; 2013 Jun; 6(3):277-86. PubMed ID: 23782082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which is the preferred blood product for fibrinogen replacement in the bleeding patient with acquired hypofibrinogenemia-cryoprecipitate or fibrinogen concentrate?
    Cushing MM; Haas T; Karkouti K; Callum J
    Transfusion; 2020 Jun; 60 Suppl 3():S17-S23. PubMed ID: 32478877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical evaluation of cryoprecipitate for replacement of fibrinogen.
    Sørensen B; Bevan D
    Br J Haematol; 2010 Jun; 149(6):834-43. PubMed ID: 20456356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of cryoprecipitate in the treatment of acquired hypofibrinogenaemia.
    Idris SF; Hadjinicolaou AV; Sweeney M; Winthrop C; Balendran G; Besser M
    Br J Haematol; 2014 Aug; 166(3):458-61. PubMed ID: 24725203
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding.
    Levy JH; Szlam F; Tanaka KA; Sniecienski RM
    Anesth Analg; 2012 Feb; 114(2):261-74. PubMed ID: 21965371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy.
    Levy JH; Welsby I; Goodnough LT
    Transfusion; 2014 May; 54(5):1389-405; quiz 1388. PubMed ID: 24117955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro efficacy of RiaSTAP after rapid reconstitution.
    Karri JV; Cardenas JC; Johansson PI; Matijevic N; Cotton BA; Wade CE; Holcomb JB
    J Surg Res; 2014 Aug; 190(2):655-61. PubMed ID: 24602482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Whether fibrinogen concentrates are necessary in Russia?].
    Galstian GM; Berkovskiĭ AL; Zhuravlev VV; Polokhov DM; Savchenko VG
    Anesteziol Reanimatol; 2014; (3):49-59. PubMed ID: 25306685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial.
    Galas FR; de Almeida JP; Fukushima JT; Vincent JL; Osawa EA; Zeferino S; Câmara L; Guimarães VA; Jatene MB; Hajjar LA
    J Thorac Cardiovasc Surg; 2014 Oct; 148(4):1647-55. PubMed ID: 24951020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cryoprecipitate: that old unknown.
    Blasi A; Beltran J; Pereira A; Puig L
    Rev Esp Anestesiol Reanim; 2015 Apr; 62(4):204-12. PubMed ID: 25561426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryoprecipitate. Patterns of use.
    Pantanowitz L; Kruskall MS; Uhl L
    Am J Clin Pathol; 2003 Jun; 119(6):874-81. PubMed ID: 12817436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Required laboratory examination and blood transfusion therapy in massive hemorrhage during surgery].
    Yamamoto K
    Rinsho Byori; 2011 Jul; 59(7):678-83. PubMed ID: 21874794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of afibrinogenemia in a chihuahua.
    Chambers G
    J Am Anim Hosp Assoc; 2013; 49(1):70-4. PubMed ID: 23148136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen concentrate for acquired hypofibrinogenaemic states.
    Weinkove R; Rangarajan S
    Transfus Med; 2008 Jun; 18(3):151-7. PubMed ID: 18598277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cryoprecipitate in human and canine transfusion medicine.
    Prittie J
    J Vet Emerg Crit Care (San Antonio); 2021 Mar; 31(2):204-214. PubMed ID: 33751762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for a phase III, non-inferiority, randomised comparison of a new fibrinogen concentrate versus cryoprecipitate for treating acquired hypofibrinogenaemia in bleeding cardiac surgical patients: the FIBRES trial.
    Karkouti K; Callum J; Rao V; Heddle N; Farkouh ME; Crowther MA; Scales DC
    BMJ Open; 2018 Apr; 8(4):e020741. PubMed ID: 29678987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial.
    Rahe-Meyer N; Hanke A; Schmidt DS; Hagl C; Pichlmaier M
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3 Suppl):S178-85. PubMed ID: 23410777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of Fibrinogen Concentrate vs Cryoprecipitate for Treating Acquired Hypofibrinogenemia in Bleeding Adult Cardiac Surgical Patients.
    Abrahamyan L; Tomlinson G; Callum J; Carcone S; Grewal D; Bartoszko J; Krahn M; Karkouti K
    JAMA Surg; 2023 Mar; 158(3):245-253. PubMed ID: 36598773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryoprecipitate: no longer the best therapeutic choice in congenital fibrinogen disorders?
    Bevan DH
    Thromb Res; 2009 Dec; 124 Suppl 2():S12-6. PubMed ID: 20109651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen concentrate--a potential universal hemostatic agent.
    Fenger-Eriksen C; Ingerslev J; Sørensen B
    Expert Opin Biol Ther; 2009 Oct; 9(10):1325-33. PubMed ID: 19645632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.